Scott Schultz, MD
Ophthalmology · Hilton Head Island, SCNPI 1841458056
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $12,250 of the $19,847 with a category attached, or 61.7%. Rxsight Inc accounts for 62.9% of it on its own, with 26 other manufacturers making up the rest. 2025 is the largest year on record at $8,821, 9.5 times the $933 reported in 2019. Among ophthalmology clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 240 payments — averaging $82.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Rxsight Inc$12K
- AbbVie$2K
- Alcon$973
- Johnson & Johnson Surgical Vision, Inc.$834
- NEW World Medical,inc.$602
- Bausch & Lomb, A Division Of Bausch Health US, LLC$322
- plus $2K from 21 others
What the payments were for
- Consulting fees$12,25062%
- Travel & lodging$6553%
- Food & beverage$6,78534%
- Education$1381%
- Gifts$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Rxsight Inc | 14 | $12,477 |
| AbbVie(2 entities) | 59 | $2,230 |
| Alcon | 28 | $973 |
| Johnson & Johnson Surgical Vision, Inc. | 20 | $834 |
| NEW World Medical,inc. | 10 | $602 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 18 | $322 |
| Harrow Eye, LLC | 5 | $320 |
| Sun Pharmaceutical Industries Inc. | 28 | $271 |
| Mallinckrodt Hospital Products Inc. | 8 | $269 |
| Aerie Pharmaceuticals, Inc. | 11 | $222 |
| Glaukos Corporation | 5 | $208 |
| Stryker | 2 | $197 |
| Bausch & Lomb Americas Inc. | 7 | $141 |
| Kala Pharmaceuticals, Inc. | 2 | $137 |
| Ocular Therapeutix, Inc. | 1 | $115 |
| Tarsus Pharmaceuticals, Inc. | 3 | $79 |
| Omeros Corporation | 3 | $68 |
| Novartis | 3 | $58 |
| Staar Surgical Company | 1 | $58 |
| Edwards Lifesciences | 1 | $57 |
| Shire North American Group Inc | 3 | $46 |
| Thea Pharma Inc. | 2 | $46 |
| Biotissue Holdings Inc. | 1 | $30 |
| Sight Sciences, Inc. | 2 | $26 |
| Eyevance Pharmaceuticals LLC | 1 | $23 |
| Rayner Intraocular Lenses Limited | 1 | $19 |
| Carl Zeiss Meditec AG | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RXSIGHT CONTACT LENS$12,250
- RXSIGHT INJECTOR CARTRIDGE$12,250
- RXSIGHT INJECTOR HANDPIECE$12,250
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$12,250
- LIGHT ADJUSTABLE LENS (LAL)$12,250
- XEN GLAUCOMA TREATMENT SYSTEM$856
- Tecnis IOL$329
- Kahook Dual Blade$302
- Ahmed Glaucoma Valve$302
- Centurion$252
- IHEEZO$208
- Streamline Surgical System$202
- Clareon$150
- TRIATHLON$133
- DURYSTA$125
- INVELTYS$116
- DEXTENZA$115
- iStent infinite Trabecular Micro-Bypass System Model iS3$113
- Clearpath$100
- Streamline$100
How this compares
$19,847 in reported general payments places this provider in the 90th percentile of 293 ophthalmology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 481 | $230,510 |
| CombiganBrimonidine Tartrate/Timolol | 260 | $99,213 |
| RhopressaNetarsudil Mesylate | 136 | $66,817 |
| Alphagan PBrimonidine Tartrate | 170 | $54,055 |
| RocklatanNetarsudil Mesylat/Latanoprost | 71 | $37,791 |
| RestasisCyclosporine | 23 | $29,532 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 143 | $24,202 |
| VyzultaLatanoprostene Bunod | 53 | $23,910 |
| Travoprost | 112 | $21,472 |
| Brimonidine Tartrate | 360 | $19,360 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 82 | $18,261 |
| Dorzolamide-TimololDorzolamide/Timolol/Pf | 113 | $17,454 |
| Latanoprost | 1,470 | $16,979 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 878 | $15,709 |
| MieboPerfluorohexyloctane/Pf | 12 | $15,686 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan, Combigan, Alphagan P, Restasis | $2,230 | $413,309934 claims |
| Aerie Pharmaceuticals, Inc.Rhopressa, Rocklatan | $222 | $104,608207 claims |
| Bausch & Lomb Americas Inc.Vyzulta, Miebo | $141 | $39,59765 claims |
| AlconSimbrinza | $973 | $18,26182 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLotemax Sm, Prolensa, Loteprednol Etabonate | $322 | $17,85277 claims |
| Thea Pharma Inc.Iyuzeh | $46 | $10,55822 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 293 ophthalmology providers in South Carolina.
Other ophthalmology in Hilton Head Island
- Joseph BishopHilton Head Island$136K
- Kerry SolomonMt Pleasant$1.7M
- William ClarkWest Columbia$768K
- George WaringMt Pleasant$645K
- Karolinne RochaCharleston$552K
- Erik HappMt Pleasant$124K
- Matthew ClaryColumbia$119K
- Kunal KanitkarLexington$83K
- Carl SloanMyrtle Beach$78K
- David VromanLadson$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.